Conus medullaris involvement in demyelinating disorders of the CNS: A comparative study

被引:11
|
作者
Etemadifar, Masoud [1 ,2 ]
Salari, Mehri [3 ]
Kargaran, Parisa K. [4 ]
Sigari, Amirhossein Akhavan [2 ]
Nouri, Hosein [2 ,5 ]
Etemadifar, Fatemeh [2 ]
Ebrahimi, Sara [2 ]
Sayahi, Newsha [2 ,6 ]
Sedaghat, Nahad [2 ,5 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Neurosurg, Esfahan, Iran
[2] Isfahan Univ Med Sci, Alzahra Univ Hosp, Alzahra Res Inst, Esfahan, Iran
[3] Shahid Beheshti Univ Med Sci, Dept Neurol Dis, Tehran, Iran
[4] Mayo Clin, Ctr Regenerat Med, Dept Cardiovasc Med, Rochester, MN 55905 USA
[5] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Esfahan, Iran
[6] Islamic Azad Univ, Fac Med, Dept Neurol, Esfahan, Iran
关键词
Demyelinating diseases; Neuromyelitis optica spectrum disorders; Multiple sclerosis; Myelin oligodendrocyte glycoprotein antibody; disorder; Conus medullaris; OLIGODENDROCYTE GLYCOPROTEIN MOG; MYELIN; CRITERIA; AQP4;
D O I
10.1016/j.msard.2021.103127
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Differentiation of the demyelinating disorders of the CNS seems challenging in practice. Conus medullaris, the cone-shaped end of the spinal cord, is more involved in anti-MOG patients based on preliminary studies, a possibly helpful detail in its differentiation. Nevertheless, the evidence is still limited and the underlying cause is unclear and undiscussed in previous studies. Objective: To contribute to preliminary studies by comparing conus involvement among patients with MS, antiAQP4, and anti-MOG diseases using larger sample size. Methods: More than a thousand MS, anti-AQP4, and anti-MOG patients were followed up for a maximum of five years, scanned for conus medullaris involvement. Data regarding each cohort were then analyzed and compared using statistical methods. Results: The rate of conus medullaris involvement was significantly higher in anti-MOG patietns (OR = 27.109, P < 0.001), followed by anti-AQP4 (OR = 4.944, P = 0.004), and MS patients (OR = reference). Survival analysis showed higher pace and cumulative incidence of conus attacks in anti-MOG patients. Conus-involved patients, showed no significant difference regarding age, sex, concurrent brain lesions, and their partial recovery. Predictive values show that the probability of being diagnosed with anti-MOG is roughly 13 times higher in conusinvolved patients (25.93% vs. 1.97%), although this probability was still higher for MS, as it has a much higher incidence. Conclusion: Despite minor differences, the results were in line with previous studies, confirming the higher rate of conus medullaris involvement among anti-MOG patients. Potential underlying causes are proposed and remain to be investigated in future studies.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chinese Han patients
    Zhou, Lei
    Huang, Yongheng
    Li, Haiqing
    Fan, Jie
    Zhangbao, Jingzi
    Yu, Hai
    Li, Yuxin
    Lu, Jiahong
    Zhao, Chongbo
    Lu, Chuanzhen
    Wang, Min
    Quan, Chao
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 305 : 19 - 28
  • [42] Clinical Profile of Primary Central Nervous System Demyelinating Disorders: A Tertiary Care Hospital-Based Study in Guwahati
    Manisha, Manisha
    Mahanta, Anirban
    Goswami, Munindra
    Das, Marami
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2022, 13 (03) : 154 - 160
  • [43] Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders
    Masciocchi, Stefano
    Businaro, Pietro
    Greco, Giacomo
    Scaranzin, Silvia
    Malvaso, Antonio
    Morandi, Chiara
    Zardini, Elisabetta
    Risi, Mario
    Vegezzi, Elisa
    Diamanti, Luca
    Bini, Paola
    Siquilini, Sabrina
    Giannoccaro, Maria Pia
    Morelli, Luana
    Liguori, Rocco
    Patti, Francesco
    De Giuli, Valeria
    Portaccio, Emilio
    Zanetta, Chiara
    Bergamoni, Stefania
    Simone, Anna Maria
    Lanzillo, Roberta
    Bruno, Giorgia
    Gallo, Antonio
    Bisecco, Alvino
    Di Filippo, Massimiliano
    Pauri, Flavia
    Toriello, Antonella
    Barone, Paolo
    Tazza, Francesco
    Bucello, Sebastiano
    Banfi, Paola
    Fabris, Martina
    Volonghi, Irene
    Raciti, Loredana
    Vigliani, Maria Claudia
    Bocci, Tommaso
    Paoletti, Matteo
    Colombo, Elena
    Filippi, Massimo
    Pichiecchio, Anna
    Marchioni, Enrico
    Franciotta, Diego
    Gastaldi, Matteo
    Neuroimmunology Platform Study Group PN, I
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2025, 12 (02):
  • [44] Distinct myeloid population phenotypes dependent on TREM2 expression levels shape the pathology of traumatic versus demyelinating CNS disorders
    Gao, Han
    Di, Jiawei
    Clausen, Bettina Hjelm
    Wang, Nanxiang
    Zhu, Xizhong
    Zhao, Tianlun
    Chang, Yanyu
    Pang, Mao
    Yang, Yang
    He, Ronghan
    Wang, Yuge
    Zhang, Liangming
    Liu, Bin
    Qiu, Wei
    Lambertsen, Kate Lykke
    Brambilla, Roberta
    Rong, Limin
    CELL REPORTS, 2023, 42 (06):
  • [45] A comparative analysis of demographic, clinical and imaging features of myelin oligodendrocyte glycoprotein antibody positive, aquaporin 4 antibody positive, and double seronegative demyelinating disorders-An Indian tertiary care center prospective study
    Salunkhe, Manish
    Gupta, Pranjal
    Singh, Rajesh Kumar
    Elavarasi, Arunmozhimaran
    Vibha, Deepti
    Garg, Ajay
    Bhatia, Rohit
    Tripathi, Manjari
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2023, 14 (02) : 313 - 319
  • [46] Investigation of ischemic and demyelinating lesions by cerebral vasoreactivity based on transcranial Doppler sonography: a comparative study
    Zoghi, Anahita
    Petramfar, Peyman
    Nikseresht, Alireza
    Sakhaee, Ehsan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2323 - 2328
  • [47] Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
    Wagner, Franca
    Grunder, Lorenz
    Hakim, Arsany
    Kamber, Nicole
    Horn, Michael P.
    Muellner, Julia
    Hoepner, Robert
    Wiest, Roland
    Metz, Imke
    Chan, Andrew
    Salmen, Anke
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [48] NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study
    Apiwattanakul, Metha
    Kasemsuk, Chayut
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (01) : 61 - 66
  • [49] A comparative study of alteration in retinal layer segmentation alteration by SD-OCT in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis
    Fu, Junxia
    Tan, Shaoying
    Peng, Chunxia
    Zhou, Huanfen
    Wei, Shihui
    ADVANCES IN OPHTHALMOLOGY PRACTICE AND RESEARCH, 2021, 1 (01):
  • [50] Comparative study of PROMIS® self-efficacy for managing chronic conditions across chronic neurologic disorders
    Shulman, Lisa M.
    Velozo, Craig
    Romero, Sergio
    Gruber-Baldini, Ann L.
    QUALITY OF LIFE RESEARCH, 2019, 28 (07) : 1893 - 1901